Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal

Autor: Daniela Fonseca e Silva, Paulo Dias Silva, Ana Torgal, Sara Braga, Diana Rocha, Carlos Ochoa, Álvaro Oliveira, Luís Rocha, Joana Marinho Dias, Inês Baldaque

Publikováno v: Acta Médica Portuguesa, Vol 34, Iss 6 (2021)

N/a.

Externí odkaz: https://doaj.org/article/17eeaf6871d0452fb6cae8c1af4247c4

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

Autor: Jia Zhe Su, Michael H. Malim, Daniel Cox, Neophytos Kouphou, Sam Acors, Carl Graham, Ana Maria Ortega-Prieto, Luke B Snell, Cassandra Fairhead, Stuart J. D. Neil, Liane Dupont, Helena Winstone, Thomas Lechmere, Rui Pedro Galão, Sadie R. Hallett, Gaia Nebbia, Isabella Huettner, Nathalia Almeida, Marie Jose Lista, Adela Alcolea-Medina, Thomas J. A. Maguire, Suzanne Pickering, Manu Shankar-Hari, Rahul Batra, Jonathan D. Edgeworth, Jose M. Jimenez-Guardeño, Katie J. Doores, Ruth E Dickenson, Jeffrey Seow, Themoula Charalampous, Harry Wilson, Blair Merrick

Publikováno v: Nature Microbiology
Dupont, L, Snell, L B, Graham, C, Seow, J, Merrick, B, Lechmere, T, Maguire, T J A, Hallett, S R, Pickering, S, Charalampous, T, Alcolea-Medina, A, Huettner, I, Jimenez-Guardeño, J M, Acors, S, Almeida, N, Cox, D, Dickenson, R E, Galao, R P, Kouphou, N, Lista, M J, Ortega-Prieto, A M, Wilson, H, Winstone, H, Fairhead, C, Su, J Z, Nebbia, G, Batra, R, Neil, S, Shankar-Hari, M, Edgeworth, J D, Malim, M H & Doores, K J 2021, ' Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern ', Nature Microbiology, vol. 6, no. 11, pp. 1433-1442 . https://doi.org/10.1038/s41564-021-00974-0

COVID-19 vaccine design and vaccination rollout need to take into account a detailed understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and emerging variants of concern (VOCs). Analyses of convalescent sera provi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5faf396a883d2efccb60cc07135362b
http://europepmc.org/articles/PMC8556155

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels:A Randomized Controlled Trial

Autor: Jens D, Lundgren, Birgit, Grund, Christina E, Barkauskas, Thomas L, Holland, Robert L, Gottlieb, Uriel, Sandkovsky, Samuel M, Brown, Kirk U, Knowlton, Wesley H, Self, D Clark, Files, Mamta K, Jain, Thomas, Benfield, Michael E, Bowdish, Bradley G, Leshnower, Jason V, Baker, Jens-Ulrik, Jensen, Edward M, Gardner, Adit A, Ginde, Estelle S, Harris, Isik S, Johansen, Norman, Markowitz, Michael A, Matthay, Lars, Østergaard, Christina C, Chang, Anna L, Goodman, Weizhong, Chang, Robin L, Dewar, Norman P, Gerry, Elizabeth S, Higgs, Helene, Highbarger, Daniel D, Murray, Thomas A, Murray, Ven, Natarajan, Roger, Paredes, Mahesh K B, Parmar, Andrew N, Phillips, Cavan, Reilly, Adam W, Rupert, Shweta, Sharma, Kathryn, Shaw-Saliba, Brad T, Sherman, Marc, Teitelbaum, Deborah, Wentworth, Huyen, Cao, Paul, Klekotka, Abdel G, Babiker, Victoria J, Davey, Annetine C, Gelijns, Virginia L, Kan, Mark N, Polizzotto, B Taylor, Thompson, H Clifford, Lane, Christine, Wenner

Publikováno v: ACTIV-3/TICO Bamlanivimab Study Group & Nielsen, H 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234–243 . https://doi.org/10.7326/M21-3507
Ann Intern Med
Annals of Internal Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
ACTIV-3/TICO Bamlanivimab Study Group & Østergaard, L J 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243 . https://doi.org/10.7326/M21-3507
ACTIV-3/TICO Bamlanivimab Study Group* & Johansen, I S 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243 . https://doi.org/10.7326/M21-3507

BACKGROUND: In a randomized, placebo-controlled, clinical trial, bamlanivimab, a SARS-CoV-2-neutralizing monoclonal antibody, given in combination with remdesivir, did not improve outcomes among hospitalized patients with COVID-19 based on an early f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c47486ea46158d87443ce42801dba2f
https://vbn.aau.dk/da/publications/c530ec33-9c51-477d-98fa-36df01391484

Modern views about reproductive health and potential in women with HIV infection and viral blood-borne hepatitis

Autor: E. V. Timofeyeva, O. Y. Leshchenko

Publikováno v: Acta Biomedica Scientifica, Vol 0, Iss 3, Pp 128-133 (2014)

The article presents a review of literature devoted to the epidemiology of HIV infection in the world and Russia, as well as the investigation of reproductive disorders in women with HIV infection and viral blood-borne hepatitis. Actuality of the pro

Externí odkaz: https://doaj.org/article/a55dfd83ccee4470ae1caac2a4f08152

Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians

Autor: Thi H. O. Nguyen, Jane Davies, Aeron C. Hurt, Carolien E van de Sandt, Malet Aban, Damian A. Oyong, Marios Koutsakos, Kim L. Harland, Steven Y. C. Tong, Jessica R. Webb, Katie L. Flanagan, Cath Blacker, Adam K. Wheatley, Peter C. Doherty, Jane Nelson, Louise C. Rowntree, Amy W. Chung, Timon Damelang, Anngie Everitt, Katherine Kedzierska, Maria Auladell, E. Bridie Clemens, Stephen J. Kent, Luca Hensen, Magdalena Plebanski, Bruce D. Wines, Jessica R. Loughland, P. Mark Hogarth, Adrian Miller

Publikováno v: Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 118(41). National Academy of Sciences

Significance Indigenous populations worldwide are highly susceptible to influenza virus infections. Vaccination with inactivated virus is highly recommended to protect Indigenous populations, including Indigenous Australians. There is no study to dat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8177d032c766c8c1ba09d40bd774890
https://doi.org/10.1073/pnas.2109388118